Overview

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin in patients with risk factors for heart disease.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kowa Research Europe
Treatments:
Pitavastatin
Simvastatin
Criteria
Inclusion Criteria:

- Males and females (18-75 years of age)

- At least two cardiovascular disease risk factors

- Must have been following a restrictive diet

- Diagnosis of primary hypercholesterolemia or combined dyslipidemia

Exclusion Criteria:

- Homozygous familial hypercholesterolemia

- Conditions which may cause secondary dyslipidemia

- Uncontrolled diabetes mellitus

- Abnormal pancreatic, liver or renal function

- Abnormal serum creatine kinase (CK) above the pre-specified level